Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2026-06-08 16:39:52 ET · period of report 2026-06-04 · accession 0001193125-26-261871 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-08 16:39 | 2026-06-04 | VNDA | McGuire Daniel Patrick | SVP, GC, Sec | A - Grant | $0.00 | +80.0K | 110.0K | +267% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-04 | A | A | 80,000 | $0.00 | 109,982 | D | — | — | (F1) Represents shares of common stock underlying an RSU award. The RSU vests in four (4) equal annual installments with the first annual vest taking place on June 4, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest. |